Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 58 Small Cell Lung Carcinoma 22 Carcinoma, Hepatocellular 17 Neoplasms 15 Lung Neoplasms 14 Biliary Tract Neoplasms 12 Neoplasm Metastasis 11 Breast Neoplasms 11 Recurrence 10 Squamous Cell Carcinoma of Head and Neck 9 Melanoma 9 Carcinoma 9 Advanced Solid Tumors 8 Triple Negative Breast Neoplasms 7 Stomach Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Liver Neoplasms 7 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Carcinoma, Renal Cell 6 Prostatic Neoplasms 5 Lymphoma 5 Uterine Cervical Neoplasms 4 Neoplasms by Site 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Colorectal Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pancreatic Neoplasms 3

Interventions

Temozolomide 29 Bevacizumab 14 Radiotherapy 12 Trastuzumab 10 Lomustine 9 Capecitabine 8 paclitaxel-Angiopep-2 conjugate 6 Nivolumab 6 pembrolizumab 5 dabrafenib 5 abemaciclib 5 Radiation 5 icotinib 4 Surgical Procedures, Operative 4 Paclitaxel 4 Lapatinib 4 Irinotecan 4 Flucytosine 4 Dianhydrogalactitol 4 Corticotropin-Releasing Hormone 4 Chlorotoxin 4 Carboplatin 4 vocimagene amiretrorepvec 3 verubulin 3 tucatinib 3 osimertinib 3 motexafin gadolinium 3 XL647 3 Spermine Synthase 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Brain Neoplasms × durvalumab × Clear all

NCT04538742 2025-12-08

DB-07

AstraZeneca

Phase 1/2 Active not recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡